Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model

被引:33
作者
Casey, BM [1 ]
Bawdon, RE [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Dallas, TX 75235 USA
关键词
ex vivo; protease inhibitor; placental transfer;
D O I
10.1016/S0002-9378(98)70078-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The object was to determine the placental transfer of ritonavir alone and in combination with zidovudine. STUDY DESIGN: Twelve placental perfusion studies were performed at trough (1-2 mu g/mL) and peak (similar to 20 mu g/mL) combinations of ritonavir and zidovudine. Accumulation of ritonavir was determined. RESULTS: Transfer of ritonavir at trough concentrations was undetectable (<0.025 mu g/mL). The clearance index of ritonavir at peak concentration was 0.085 +/- 0.05 and was unaffected by zidovudine. The fetal concentration of ritonavir was 0.0758 +/- 0.22 mu g/mL at a maternal concentration of similar to 20 mu g/mL and 25.5 +/- 6.9 mu g/mL at a concentration of 100 mu g/mL. There was no tissue accumulation of ritonavir either alone or with zidovudine. CONCLUSION: The clearance index of ritonavir at therapeutic levels was extremely low, with little accumulation in the fetal compartment and no accumulation in placental tissue. Zidovudine does not significantly affect the transfer or accumulation of ritonavir.
引用
收藏
页码:758 / 761
页数:4
相关论文
共 19 条
  • [1] THE TRANSFER OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS NUCLEOSIDE COMPOUNDS BY THE TERM HUMAN PLACENTA
    BAWDON, RE
    SOBHI, S
    DAX, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (06) : 1570 - 1574
  • [2] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel
    Carpenter, CCJ
    Fischl, MA
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schooley, RT
    Thompson, MA
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969
  • [3] Challier J C, 1985, Contrib Gynecol Obstet, V13, P32
  • [4] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT
    CONNOR, EM
    SPERLING, RS
    GELBER, R
    KISELEV, P
    SCOTT, G
    OSULLIVAN, MJ
    VANDYKE, R
    BEY, M
    SHEARER, W
    JACOBSON, RL
    JIMENEZ, E
    ONEILL, E
    BAZIN, B
    DELFRAISSY, JF
    CULNANE, M
    COOMBS, R
    ELKINS, M
    MOYE, J
    STRATTON, P
    BALSLEY, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) : 1173 - 1180
  • [5] A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE
    DANNER, SA
    CARR, A
    LEONARD, JM
    LEHMAN, LM
    GUDIOL, F
    GONZALES, J
    RAVENTOS, A
    RUBIO, R
    BOUZA, E
    PINTADO, V
    AGUADO, AG
    DELOMAS, JG
    DELGADO, R
    BORLEFFS, JCC
    HSU, A
    VALDES, JM
    BOUCHER, CAB
    COOPER, DA
    GIMENO, C
    CLOTET, B
    TOR, J
    FERRER, E
    MARTINEZ, PL
    MORENO, S
    ZANCADA, G
    ALCAMI, J
    NORIEGA, AR
    PULIDO, F
    GLASSMAN, HN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) : 1528 - 1533
  • [6] Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission - Effect of maternal zidovudine treatment on viral load
    Dickover, RE
    Garratty, EM
    Herman, SA
    Sim, MS
    Plaeger, S
    Boyer, PJ
    Keller, M
    Deveikis, A
    Stiehm, ER
    Bryson, YJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (08): : 599 - 605
  • [7] Duff P., 1996, Primary Care Update for Ob/Gyns, V3, P45, DOI 10.1016/S1068-607X(95)00062-N
  • [8] RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION THROUGH BREAST-FEEDING
    DUNN, DT
    NEWELL, ML
    ADES, AE
    PECKHAM, CS
    [J]. LANCET, 1992, 340 (8819) : 585 - 588
  • [9] GALLANT JE, 1996, HOPKINS HIV REP, V8, P1
  • [10] SAFETY AND ACTIVITY OF SAQUINAVIR IN HIV-INFECTION
    KITCHEN, VS
    SKINNER, C
    ARIYOSHI, K
    LANE, EA
    DUNCAN, IB
    BURCKHARDT, J
    BURGER, HU
    BRAGMAN, K
    PINCHING, AJ
    WEBER, JN
    [J]. LANCET, 1995, 345 (8955): : 952 - 955